慢性肢体威胁性缺血患者踝下动脉穿刺后的血管与创面愈合结局
本研究为单中心回顾性非随机观察性研究,分析171条患肢(155例患者,平均年龄76.1±9.4岁)因慢性肢体威胁性缺血(Rutherford 5-6级)接受踝下远端穿刺腔内治疗后的血管完整性与创面愈合情况。穿刺点狭窄占83.0%,中位血管直径1.8 mm,中位随访13.1个月,Kaplan-Meier估计1年创面愈合率为57.3%,穿刺点慢性闭塞发生率为32.2%。结论认为狭窄动脉的踝下远端穿刺可能在创面愈合前导致穿刺点闭塞,需密切监测直至创面愈合。
要点
- 穿刺点狭窄占83.0%,中位血管直径1.8 mm,1年创面愈合率为57.3%。
- 穿刺点慢性闭塞发生率为32.2%,小血管直径(评分2,<1.5 mm)OR为10.8。
- 作者建议需要远端穿刺时选择直径较大、病变负担较小的目标血管。
核心结论
- 狭窄动脉的踝下远端穿刺可能在创面愈合前导致穿刺点闭塞。
- 若穿刺部位远端血管为创面供血,作者认为用多普勒或其他影像学密切监测以发现闭塞直至创面愈合至关重要。
- 作者认为需要远端穿刺时,选择直径较大且病变负担较小的目标血管可能降低慢性闭塞风险并有助于防止创面愈合延迟。
研究设计与样本
- 单中心、回顾性、非随机、观察性研究。
- 分析2014年1月至2024年12月间171条患肢(155例患者,平均年龄76.1±9.4岁;74.2%合并糖尿病;48.4%接受血液透析)。
- 患者为慢性肢体威胁性缺血(Rutherford 5-6级),因新发膝下动脉病变(97.1%为闭塞)接受踝下远端穿刺腔内治疗。
主要发现
- 穿刺点狭窄占83.0%,中位血管直径1.8 mm。
- 中位随访13.1个月,Kaplan-Meier估计1年创面愈合率为57.3%。
- 穿刺点慢性闭塞(定义为初始血运重建后血管闭塞)发生率为32.2%。
- 穿刺点慢性闭塞的独立预测因素:血液透析的肾衰竭(OR 2.76;95%CI 1.12-6.81;P = .028)、GLASS P2修饰因子(OR 2.89;95%CI 1.15-7.28;P = .024)、穿刺远端血管直径较小(评分0为>2.0 mm、1为1.5-2.0 mm、2为<1.5 mm;OR 10.8;95%CI 4.11-28.3;P < .001)。
- 血管直径预测穿刺点慢性闭塞的ROC曲线下面积为0.88,Youden J统计量提示截断值为1.7 mm。
关键数值与推荐
- 穿刺点狭窄占83.0%,中位血管直径1.8 mm。
- 穿刺点慢性闭塞发生率32.2%,1年创面愈合率57.3%。
- 血管直径评分:0为>2.0 mm,1为1.5-2.0 mm,2为<1.5 mm。
- 血管直径预测穿刺点慢性闭塞的ROC曲线下面积0.88,Youden J统计量提示截断值1.7 mm。
临床怎么用
- 作者认为若穿刺部位远端血管为创面供血,应用多普勒或其他影像学密切监测以发现闭塞直至创面愈合。
- 作者认为需要远端穿刺时,选择直径较大且病变负担较小的目标血管可能降低慢性闭塞风险并有助于防止创面愈合延迟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluated the safety of below-the-ankle distal punctures, including stenotic or small-diameter inframalleolar arteries, on vessel integrity and wound healing in patients with chronic limb-threatening ischemia and infrapopliteal artery disease. METHODS: This single-center, retrospective, nonrandomized, observational study analyzed 171 limbs from 155 patients (mean age, 76.1 ± 9.4 years; 74.2% with diabetes mellitus; 48.4% undergoing hemodialysis) with chronic limb-threatening ischemia (Rutherford classification 5-6) who underwent endovascular therapy using below-the-ankle distal punctures for de novo infrapopliteal disease (97.1% occlusion) between January 2014 and December 2024. RESULTS: Stenosis at puncture sites were observed in 83.0% of the cases, with a median vessel diameter of 1.8 mm. During a median follow-up of 13.1 months, the Kaplan-Meier-estimated 1-year wound healing rate was 57.3%. Chronic occlusion at puncture sites, defined as vessel occlusion after initial revascularization, occurred in 32.2% of the cases. Multivariate analysis identified renal failure on hemodialysis (odds ratio [OR], 2.76; 95% confidence interval [CI], 1.12-6.81; P = .028), the Global Limb Anatomical Staging System P2 modifier (OR, 2.89; 95% CI, 1.15-7.28; P = .024), and smaller distal puncture vessel sizes (scored as 0 [>2.0 mm], 1 [1.5-2.0 mm], or 2 [<1.5 mm]; OR, 10.8; 95% CI, 4.11-28.3; P < .001) as independent predictors of chronic occlusion at the puncture sites. The area under the receiver operating characteristic curve for vessel diameter in predicting chronic occlusion at the puncture site was 0.88, with the Youden J statistic indicating a cutoff value of 1.7 mm. Multivariate analysis showed that an increased foot infection grade (hazard ratio [HR], 0.71; 95% CI, 0.51-0.99; P = .043), a small artery disease score of 2 (HR, 0.54; 95% CI, 0.30-0.98; P = .042), and a chronic occlusion at the puncture site (HR, 0.51; 95% CI, 0.28-0.92; P = .025) were independent risk factors for impaired wound healing. CONCLUSIONS: Below-the-ankle distal punctures in stenotic arteries may cause puncture site occlusions before wound healing. If distal vessels at the puncture site supply the wound, close monitoring with Doppler or other imaging is essential to detect occlusions until the wound heals. When distal puncture is needed, selecting a target vessel with a larger diameter and minimal disease burden may lower the risk of chronic occlusions and help prevent delays in wound healing.
引用
- Iwata S, Tan M, Miwa T, et al. Vascular and wound healing outcomes after puncture of small or stenotic inframalleolar arteries in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 40409432. doi:10.1016/j.jvs.2025.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。